News and Press Releases Archive
   
December 21, 2011 Links to articles appearing on international websites and in the media, concerning ViroStatics during 2011
Press Review - Rassegna Stampa 2011
   
November 7, 2011 ViroStatics' President and CEO, Dr. Franco Lori, presents at the Second National Health Research Conference in Cernobbio, Italy.

Conference Programme
   
October 31, 2011  ViroStatics will be at BIO-Europe 2011 in Duesseldorf, Germany. BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies.
   
October 27, 2011 ViroStatics is pleased to announce their participation in the 2nd International Workshop on HIV & Aging organized in Baltimore by Virology Education, with the presentation entitled: "AntiViral-Hyperactivation Limiting Therapeutics reduce both HIV and immune hyperactivation restoring immune system damage. A Clinical Proof of Concept."
   
October 24, 2011 ViroStatics' CEO, Dr. Franco Lori, will be an invited speaker at Pennsylvania Biotech 2011 in Philadelphia, Pennsylvania, USA.
   
July 20, 2011 ViroStatics' Chief Executive Officer, Dr. Franco Lori, gave a "Late Breaker" presentation entitled "Depletion of naïve CD4+T cell compartment by immune hyperactivation can be rapidly reversed by AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs)" during the International AIDS Society conference (IAS 2011) in Rome, Italy.

Press Release document.pdf
Comunicato Stampa.pdf
   
June 20, 2011 ViroStatics CEO, Franco Lori, MD, will be an invited speaker at the June 2011 BIO International Convention in Washington, DC.
   
April 6, 2011 Online links to articles and videos on ViroStatics' Scientific findings published on International websites after CROI 2011

Press review
Rassegna stampa
   
March 2, 2011 ViroStatics is pleased to announce their participation in the CROI 2011 conference in Boston with the presentation "Prompt, Significant Reduction of Activation and Proliferation Markers in CD4+ and CD8+ T Cell Subsets Despite Incomplete Viral Suppression: Proof-of-Concept for AV-HALTs: New Class of Anti-HIV Therapeutics Inhibiting Both HIV Replication and Immune Activation"

Press Release Article
Comunicato stampa
   
February 15, 2011 ViroStatics' Chief Executive Officer, Dr. Franco Lori, gave an invited presentation entitled "Dual Inhibitors of HIV Replication and Immune Hyperactivation" during a Scientific Seminar organized by the Sardinian Science and Technology Park in Pula (Southern Sardinia), Italy

Related article
Articolo correlato
   
October 30, 2010 ViroStatics announces the publication on the scientific journal British Journal of Pharmacology of the article "Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in HIV/AIDS"
   
July 22, 2010 Immunacia's ViroStatics and Genetic Immunity are pleased to announce their participation in the "NAPWA Community Research Forum, Research Advances from Therapeutic HIV Vaccines and Other Immune-Based Therapies" during the XVIII International AIDS Conference, Vienna, Austria
   
July 19, 2010 Immunacia's ViroStatics reports Phase II data on VS411, an AV-HALT for treating HIV/AIDS, during the XVIII International AIDS Conference, Vienna, Austria
   
June 11, 2010 ViroStatics and Vichem Chemie Announce Strategic Partnership to Identify and Develop Kinase Inhibitors for the Treatment of HIV/AIDS and Other Chronic Diseases
   
May 3, 2010 Dr. James Chafouleas, former Head of Global Licensing – Virology at Boehringer Ingelheim Canada (Ltd.), Joins ViroStatics and Genetic Immunity as Strategic Adviser
   
March 1, 2010 ViroStatics organizes a Seminar "High-End Flow cytometry analysis for everyone". The event will take place at Porto Conte Ricerche, Alghero (Room Anghelu Ruju) from 11.00 till 13.00
   
May 20, 2009 ViroStatics' Dr. Franco Lori to Present During 2009 BIO International Convention in Atlanta
   
March 29, 2009 ViroStatics acquires Library of Oncological/Antiviral Compounds from the University of Siena
   
March 18, 2009 ViroStatics' Chief Executive Officer, Dr. Franco Lori, to Present During BIO-Europe Spring 2009 on 18 March 2009
   
December 10, 2008 ViroStatics' President and CEO, Dr. Franco Lori, to address HIV DART 2008 in Puerto Rico
   
November 12, 2008 The CDO, Dr. Michael Stevens, Presenting During Rodman & Renshaw's Tenth Annual Global Healthcare Conference
   
October 1, 2008 The CEO, Dr. Franco Lori, speaking at the prestigious 2nd World Conference on Magic Bullets, (Ehrlich II) in Nürnberg, Germany on Saturday, October 4th 2008
   
May 28, 2008 Franco Lori on Sky Radio
   
May 26, 2008 ViroStatics on IMS Health Company Focus
   
May 13, 2008 ViroStatics Doses First Patient in Phase IIa Trial of VS411 for the Treatment of HIV Infection
   
February 27, 2008



ViroStatics srl - Viale Umberto I, 46 - 07100 Sassari (SS) - Italy

This site is © Copyright ViroStatics, srl All Rights Reserved - webmaster: Graphia Studio, Pavia